Save ABx Japan

抗菌薬適正使用や薬剤耐性菌に関する一般・医療者向けの情報発信をしています。学会等の公式アカウントではありません。

[yyguu @yyguu]

抗菌薬ちゃんと使おうねの動画。茨城県と筑波大学のコラボ動画だけど、これをOKする茨城県のセンスはよいと思う。内容はきわめてまっとう。
#AMR 　#薬剤耐性
https://t.co/DO6h47Ka0l

[Diane Ashiru, PhD @DrDianeAshiru]

Global research agenda for #antimicrobialresistance in human health by @WHO prioritizes 40 research topics for evidence generation to inform policy by 2030. https://t.co/YTyRbsveFe

cc #AntibioticGuardian

[ICPIC @ICPIC_meeting]

SHEA, IDSA and APIC have recently published updated recommendations on practical strategies to prevent healthcare-associated infections through hand hygiene.

Read the article here: https://t.co/TVlWXfc5eA

#InfectionControl #HygieneMatters #HandHygiene #InfectionPrevention

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

Wow!!
🔥A practice changing RCT🔥
26 US and Canada N: 887
Pip-tazo Vs Cefoxitin preop in OPEN Pancreatoduodenectomy (Whipple)
TZP as perioperative prophylaxis reduced postoperative SSI, pancreatic fistula,and multiple downstream sequelae of SSI
Cefoxitin🤔 https://t.co/eGDFZwZZbt

[Patrick Harris @padstamundo]

#ECCMID2023 EUCAST FAQs... ongoing problems with cefiderocol MIC testing has not been resolved - even the reference method has poor agreement between types of ID-CAMHB media: watch out for warning updates https://t.co/mM293XT7qP

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🆕️🔥🔥State of art review article #CMR @cairns_kel @DrTrishaPeel @AntonPeleg
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections
Thanks @BradSpellberg
#IDTwitter #VRE #LaylatulQadr
https://t.co/kQi4ynlqYO

[NHS NE&Yorks AMR - Philip HOWARD OBE @AntibioticLeeds]

Great work by @e_charani on #antibiotic #shortages 80% are from high income countries. No legal requirement to report shortages. Good news that active work is happening to overcome this. @gardp @LiverpoolCEIDR @ESGAP_ABS @BSACandJAC #ECCMID2023 OR #ECCMID23

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

GARDP warmly welcomes @WHO invite to apply to manufacture the #antibiotic, cefiderocol 😎

The move supports our commitment to increase global #access to #treatments for multi-#drugresistant #bacterialinfections

👇
https://t.co/2jTtMD9rv3

[Fiona Gotterson @FGotterson]

Antimicrobial stewardship & infection prevention/control are connected. But how do GP nurses view their contribution to AMS? #GP nurses! Please consider taking part. Or, if working with practice nurses, let them know about the survey, closes soon! https://t.co/ti4ml7nq4C

[NHS NE&Yorks AMR - Philip HOWARD OBE @AntibioticLeeds]

23% more #antibiotic prescribing in primary care in England with telephone consultations vs face-to-face. Very worrying! #ARIhubs will address this. #ECCMID2023 OR #ECCMID23 @rcgp @TARGETabx @elizbeech @JeffFeathersto8 @mattinadakim

[Bryan White @bryan_p_white]

No need for prophylaxis for transperineal prostate biopsies. #ECCMID2023

[Brad Langford @BRxAD]

Impact of #COVID19 on #AntibioticResistance is complex. Our systemic review found a trend to increasing Gram-negative AMR during the pandemic and a high degree of heterogeneity across studies. #ECCMID23 #ECCMID2023
https://t.co/dKpvoazq8y

[Akshatha R @IDdocAkshatha]

All about #Streptococcal #IE
After today's updates in #ECCMID2023 about the inclusion of various Streptococcus species in IE with few exceptions, I decided to compile a few important infographics on Streptococcal IE
1. Streptococcal grouping
2. Incidence of IE
#IDTwitter

[Akshatha R @IDdocAkshatha]

#ECCMID2023
Tissue penetration of various antifungal drugs
https://t.co/WCGrEJ7qVj

[Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 @ABsteward]

🔥 Just published 🔥 @CMIJournal
The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergy
Presented today @ESCMID #ECCMID2023 by Prof Mark De Boer
🌟Cross reactivity in beta-lactam antibiotics🌟
EnJoY
https://t.co/80zCjr1gxZ

[Sanjay Bhattacharya MD DNB FRCPath @SanjayB88114087]

Select antibiotics with activity against carbapenem-resistant organisms. Green, susceptibility anticipated to be >80%; yellow, susceptibility anticipated to be 30% to 80%; red, intrinsic resistance or susceptibility anticipated to be <30%.

[IDSA @IDSAInfo]

#COVID19Guidelines update!

IDSA has released updated evidence summaries and clarified remarks on the use of #molnupiravir in the treatment of patients with COVID-19: https://t.co/InyRvQiYjp

[新米ID @black_kghp]

令和5年2月8日にアドバイザリーボードで示された
「マスク着用の有効性に関する科学的知見」の文書を
1枚にまとめました
他者を感染させず、自分を感染させないため
科学的な知見も参考にマスク着用についてご配慮いただければ幸いです

[Antimicrobial Resistance Fighter Coalition @AMResistance]

We need to consider several different interventions to counter the threat of antimicrobial resistance (#AMR).

If we reduce the number of #antibiotics in the environment, improve infection prevention, and use diagnostics to help reduce unnecessary use, we can make a difference.